Literature DB >> 9116996

In vitro and in vivo modulation of alpha- and beta-glucocorticoid-receptor mRNA in human bronchial epithelium.

S H Korn1, E F Wouters, G Wesseling, J W Arends, F B Thunnissen.   

Abstract

Despite the central role bronchial epithelial cells play in asthmatic reactions, and the widespread use of inhaled corticosteroids in asthma, no information is available on the effect of glucocorticoids on glucocorticoid- receptor (GR) gene expression. In this study, the effect of budesonide on alpha- and beta-GR gene expression in human bronchial epithelial cells was investigated in vitro and in vivo. A bronchial epithelial cell line was exposed in vitro to budesonide, and a dose- and time-dependent synchronous downregulation of alpha- and beta-GR mRNA was observed. A 1-h exposure resulted in a reversible and reduced downregulation as compared with continuous exposure. In healthy volunteers (n = 10), no difference on average was present in GR mRNA expression before or after 4 wk of budesonide inhalation in either bronchial epithelial cells or alveolar macrophages. The time between the last inhalation and sampling of cells ranged from 0.5 to 8 h. However, a significant downregulation of alpha-GR mRNA was observed when the time between the last inhalation and sampling of cells was more than 2 h. Normalization of the downregulation of GR mRNA expression in bronchial epithelial cells is explained by the pharmacokinetics of inhaled budesonide in the human lung.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9116996     DOI: 10.1164/ajrccm.155.3.9116996

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Alpha and beta glucocorticoid receptor mRNA expression in skeletal muscle.

Authors:  S H Korn; E Koerts-de Lang; G E Engel; J W Arends; E F Wouters; F B Thunnissen
Journal:  J Muscle Res Cell Motil       Date:  1998-10       Impact factor: 2.698

2.  High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.

Authors:  R Towers; T Naftali; G Gabay; M Carlebach; A Klein; B Novis
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Cytokine release and its modulation by dexamethasone in whole blood following exercise.

Authors:  H H Smits; K Grünberg; R H Derijk; P J Sterk; P S Hiemstra
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.

Authors:  R J Hancox; D A Stevens; I M Adcock; P J Barnes; D R Taylor
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

Review 5.  Alpha and beta glucocorticoid receptors: relevance in airway diseases.

Authors:  Laura Pujols; Joaquim Mullol; César Picado
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

6.  Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells.

Authors:  Yajun Chen; Tracey J Nickola; Nancy L DiFronzo; Anamaris M Colberg-Poley; Mary C Rose
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-20       Impact factor: 6.914

7.  Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma.

Authors:  Davina C M Simoes; Anna-Maria G Psarra; Thais Mauad; Ioanna Pantou; Charis Roussos; Constantine E Sekeris; Christina Gratziou
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

Review 8.  Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.

Authors:  V H van der Velden
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  Increased expression of glucocorticoid receptor beta messenger RNA in patients with ankylosing spondylitis.

Authors:  Chang-Keun Lee; Eun Young Lee; You-Sook Cho; Keun Ae Moon; Bin Yoo; Hee-Bom Moon
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

10.  Active Ingredients of Epimedii Folium and Ligustri Lucidi Fructus Balanced GR/HSP90 to Improve the Sensitivity of Asthmatic Rats to Budesonide.

Authors:  Xiufeng Tang; Xiaoxi Li; Honglei Nian; Yan Yang; Yuheng Chen; Xiujuan Wang; Liping Xu; Xinwei Yang; Renhui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-11       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.